The Market Is Ready for Disruption
Market Opportunity
Today, collecting and reporting biosignals remains a highly manual process—labor-intensive, time-consuming, and error-prone. While some companies have tried to automate this workflow, current offerings often fall short in critical areas:
- Lack of clinical-grade data accuracy
- No seamless integration with electronic health records (EHRs)
- Limited wearability, patient comfort, or recharging options
- Short device lifespan—unable to support long-term, uninterrupted use
SleeveSense™ is designed to close every one of these gaps. The opportunity is massive. In the United States alone:
- 600,000–700,000 patients are hospitalized each day
- 2.7 million outpatient visits occur daily
- 1.4–1.7 million individuals receive home healthcare at any given time
Across these settings, studies show that nurses spend up to 20% of their time manually capturing and documenting vital signs.
Even with today’s product limitations, over 71 million patients are already using remote monitoring devices—a number projected to rise sharply as the population ages and chronic disease rates continue to climb. The macro trends are undeniable:
- A growing, aging patient population
- Escalating nursing shortages
- Rising demand for value-based care
- Healthcare systems under pressure to reduce cost while improving outcomes
Senphonix stands at the intersection of all of these forces—offering a truly continuous, clinically relevant, EHR-integrated solution built for real-world wearability and long-term use. We're not just following the trends. We're poised to define the future of continuous patient insight—for hospitals, for home care, for outpatient centers, and beyond.
At Senphonix, we understand that healthcare is more than just treating illness. It's about addressing the needs of the entire healthcare ecosystem, so that all within it can benefit. That's why we're building solutions with patients, caregivers, and healthcare systems in mind.
Stakeholder Benefits
For healthcare providers, automation will reduce the burden on staff while providing continuous patient monitoring and better health insights.
For patients, the comfortable mesh design will eliminate skin irritation and improve adherence to monitoring protocols.
For researchers and clinicians, reliable data collection will support better clinical trial outcomes and evidence-based care.
For service members, durable, real-time monitoring will enhance mission readiness and recovery processes.
For investors, it’s the chance to help correct healthcare inefficiencies and continuously increasing healthcare costs.
Investment Highlights
Very Strong Demand: With unmatched wearability, clinical-grade data, and seamless system integration, SleeveSense is set to disrupt the wearable health tech space. Market research conducted by MarketWise Advising in April 2025 has validated a market need/solution match, with 95% confidence (n=402; +/- 5% error rate).
Proven Innovation: Senphonix is already gaining traction, with strong interest from leading healthcare organizations, strategic partners, investors, and sublicensees—validating both the need and the market fit.
Defensible Intellectual Property: Senphonix holds an exclusive, worldwide license from the University of Arizona to the core intellectual property utilized in its SleeveSense product. Our software platform is generating additional IP, further strengthening our innovation moat.
Scalable, Recurring Revenue Model: Our pay-as-you-go pricing eliminates the need for upfront capital investment, lowering barriers to adoption and enabling predictable, recurring revenue.
Expanding Total Addressable Market: SleeveSense is built for broad application—from inpatient care and outpatient clinics to home health, assisted living, and even military operations. These use cases open the door to multiple billion-dollar market opportunities.
A Proven Startup Team: The startup team is second to none. With deep experience turning breakthrough ideas into market-shaping innovations, we know what it takes to bring transformative healthcare technology to market, and then to scale—because we’ve done it before, many times.
Join Us in Shaping the Future of Healthcare
We’re inviting visionary investors to partner with Senphonix as we transform how patient data is captured, connected, and acted upon—across healthcare and beyond. Your investment will accelerate our next phase of maturity, helping us to:
- Build and scale a secure, HIPAA-compliant cloud infrastructure to power SleeveSense and seamlessly integrate with leading EHRs
- Initiate and advance key regulatory milestones, including FCC, UL, and FDA submissions, ensuring a clear and efficient path to commercialization
- Expand manufacturing operations to drive down unit costs and meet rising demand across inpatient, outpatient, and home care settings
- Advance R&D efforts to refine device features, enhance the user experience, and explore new clinical and non-clinical applications
- Deploy targeted go-to-market strategies to drive adoption across multiple sectors and care environments
- Forge strategic partnerships with health systems, military organizations, and research institutions that align with our mission
This is more than a MedTech investment—it's an opportunity to help shape the future of care delivery, drive meaningful impact, and create lasting value across the healthcare ecosystem, starting with our MVP.
